9 research outputs found
Modern temporal network theory: A colloquium
The power of any kind of network approach lies in the ability to simplify a
complex system so that one can better understand its function as a whole.
Sometimes it is beneficial, however, to include more information than in a
simple graph of only nodes and links. Adding information about times of
interactions can make predictions and mechanistic understanding more accurate.
The drawback, however, is that there are not so many methods available, partly
because temporal networks is a relatively young field, partly because it more
difficult to develop such methods compared to for static networks. In this
colloquium, we review the methods to analyze and model temporal networks and
processes taking place on them, focusing mainly on the last three years. This
includes the spreading of infectious disease, opinions, rumors, in social
networks; information packets in computer networks; various types of signaling
in biology, and more. We also discuss future directions.Comment: Final accepted versio
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly Inherited Alzheimer Network and ultrasensitive immunoassay technology to demonstrate that NfL levels in the cerebrospinal fluid (n = 187) and serum (n = 405) are correlated with one another and are elevated at the presymptomatic stages of familial Alzheimer’s disease. Longitudinal, within-person analysis of serum NfL dynamics (n = 196) confirmed this elevation and further revealed that the rate of change of serum NfL could discriminate mutation carriers from non-mutation carriers almost a decade earlier than cross-sectional absolute NfL levels (that is, 16.2 versus 6.8 years before the estimated symptom onset). Serum NfL rate of change peaked in participants converting from the presymptomatic to the symptomatic stage and was associated with cortical thinning assessed by magnetic resonance imaging, but less so with amyloid-β deposition or glucose metabolism (assessed by positron emission tomography). Serum NfL was predictive for both the rate of cortical thinning and cognitive changes assessed by the Mini–Mental State Examination and Logical Memory test. Thus, NfL dynamics in serum predict disease progression and brain neurodegeneration at the early presymptomatic stages of familial Alzheimer’s disease, which supports its potential utility as a clinically useful biomarker